{"Clinical Trial ID": "NCT00418457", "Intervention": ["INTERVENTION 1:", "General anesthesia and opioid", "General anesthesia followed by opioid administration", "General anesthesia and opioids: General anesthesia, usually with sevoflurane and opioid analgesia", "INTERVENTION 2:", "Regional analgesia and propofol", "Regional anesthesia and analgesia (epidural or paravertebral) associated with propofol", "Regional analgesia and propofol: Regional anaesthesia and analgesia (epidural or paravertebral), associated with deep sedation or general anaesthesia"], "Eligibility": ["Incorporation criteria:", "Primary breast cancer without known extension beyond breast and axillary lymph nodes (i.e., believed to be the 1-3 tumour stage, knots 0-2)", "For unilateral or bilateral mastectomy with or without implant (insulated \"lumpectomy\" will not be eligible)", "\"Isolated lumpectomy\" with dissection of axillary nodes (anticipated removal of at least five knots)", "Written informed consent, including willingness to be randomized to morphine or regional analgesia", "- Exclusion criteria:", "Previous breast cancer surgery (excluding diagnostic biopsies)", "Inflammatory breast cancer", "Age < 18 years or > 85 years", "Rebuilding programmed free shutters", "ASA Physical condition 4", "Any contraindication to epidural anesthesia or paraavertebrale and analgesia (including coagulopathy, abnormal anatomy)", "Any contraindication to midazolam, propofol, sevoflurane, fentanyl or morphine", "Other cancers that the treating surgeon does not believe to be in remission in the long term", "A systemic disease that the treating surgeon believes to have 25% mortality over two years"], "Results": ["Performance measures:", "Number of participants who had a recurrence of breast cancer after breast cancer surgery", "Time required for breast cancer to recur from the end of surgery.", "Time limit: up to 10 years", "Results 1:", "Title of the arm/group: General anaesthesia and opioid", "Description of the arm/group: General anaesthesia followed by opioid administration", "General anesthesia and opioids: General anesthesia, usually with sevoflurane and opioid analgesia", "Total number of participants analysed: 1065", "Type of measurement: Number", "Unit of measure: participants 111", "Results 2:", "Title of the arm/group: Regional analgesia and propofol", "Description of the arm/group: Regional anesthesia and analgesia (epidural or paravertebral) associated with propofol", "Regional analgesia and propofol: Regional anaesthesia and analgesia (epidural or paravertebral), associated with deep sedation or general anaesthesia", "Total number of participants analysed: 1043", "Type of measurement: Number", "Unit of measure: participants 102"], "Adverse Events": ["Undesirable Events 1:", "Total: 0/1065 (0.00 per cent)", "Adverse Events 2:", "Total: 0/1043 (0.00 per cent)"]}